Stockscreener 앱 받기
92.99
0.32%
0.30
전일 마감가:
$92.69
열려 있는:
$94.34
하루 거래량:
653.28K
Relative Volume:
0.64
시가총액:
$5.39B
수익:
$360.35M
순이익/손실:
$-149.57M
주가수익비율:
-31.42
EPS:
-2.96
순현금흐름:
$-81.27M
1주 성능:
-1.38%
1개월 성능:
+6.64%
6개월 성능:
-33.71%
1년 성능:
-18.40%
1일 변동 폭
$92.92
$95.00
1주일 범위
$90.90
$96.91
52주 변동 폭
$77.10
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
명칭
Glaukos Corporation
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
GKOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
92.99 | 5.39B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-11-28 | 개시 | Truist | Buy |
| 2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-04 | 개시 | Needham | Buy |
| 2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
| 2020-12-09 | 개시 | Oppenheimer | Perform |
| 2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-06-15 | 개시 | Jefferies | Hold |
| 2020-03-05 | 개시 | Citigroup | Sell |
| 2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | 개시 | BTIG Research | Neutral |
| 2018-08-30 | 개시 | Berenberg | Hold |
| 2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-03 | 재확인 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
| 2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corporation 주식(GKOS)의 최신 뉴스
Stifel maintains buy rating on Glaukos stock, $115 target unchanged By Investing.com - Investing.com Nigeria
Glaukos at Jefferies Conference: Eyeing Interventional Success - Investing.com
Stifel maintains buy rating on Glaukos stock, $115 target unchanged - Investing.com
Glaukos at William Blair Conference: Eyeing Innovative Growth By Investing.com - Investing.com Canada
glaukos corp reports annual meeting voting results By Investing.com - Investing.com South Africa
glaukos corp reports annual meeting voting results - Investing.com
Glaukos Stockholders Approve Key Proposals at Annual Meeting - TipRanks
Glaukos at William Blair Conference: Eyeing Innovative Growth - Investing.com India
(GKOS) Trading Report - news.stocktradersdaily.com
Those who invested in Glaukos (NYSE:GKOS) three years ago are up 120% - Yahoo Finance
Glaukos at Stifel Forum: iDose Launch and Strategic Outlook - Investing.com India
Glaukos at Stifel Forum: iDose Launch and Strategic Outlook By Investing.com - Investing.com Nigeria
Glaukos Corp (GKOS) Shares Up 3.69% on May 27 - GuruFocus
Glaukos Corporation (NYSE:GKOS) Q1 2025 Earnings Call Transcript - MSN
Here's Why You Should Retain Glaukos Stock in Your Portfolio - MSN
BNP Paribas Financial Markets Trims Stock Holdings in Glaukos Co. (NYSE:GKOS) - Defense World
Those who invested in Glaukos (NYSE:GKOS) five years ago are up 156% - simplywall.st
Alex Thurman: Dealing with Too Bullish Investors - Orange County Business Journal
Glaukos Corp (GKOS) Trading 3.06% Higher on May 16 - GuruFocus
Tiny Tech, Big Impact: Glaukos Team Automates Vision-Saving Implants - University of San Diego
Research Analysts’ Recent Ratings Changes for Glaukos (GKOS) - Defense World
Glaukos Releases Its 2024 Sustainability Report - VisionMonday.com
Glaukos Highlights Innovation in May 2025 Presentation - TipRanks
Glaukos Announces Participation in Upcoming Investor ConferencesMay 13, 2025 - BioSpace
(GKOS) Trading Signals - news.stocktradersdaily.com
Glaukos Corporation (GKOS) Fell as its iDose Results Fell Short of Expectations - Insider Monkey
Hsbc Holdings PLC Decreases Position in Glaukos Co. (NYSE:GKOS) - Defense World
Interesting GKOS Put And Call Options For August 15th - Nasdaq
Glaukos (GKOS) Analyst Rating Update: Price Target Revised Downw - GuruFocus
What is William Blair’s Estimate for Glaukos Q1 Earnings? - Defense World
Stephens Issues Pessimistic Forecast for Glaukos (NYSE:GKOS) Stock Price - Defense World
Glaukos projects 2025 sales in the $475M-$485M range with strong iDose ramp - MSN
Glaukos (NYSE:GKOS) Stock Rating Lowered by Wells Fargo & Company - Defense World
Decoding Glaukos Corp (GKOS): A Strategic SWOT Insight - GuruFocus
Stephens cuts Glaukos stock price target to $115 from $140 By Investing.com - Investing.com South Africa
What 11 Analyst Ratings Have To Say About Glaukos - Benzinga
GKOS: Stephens & Co. Lowers Price Target for Glaukos to $115 | G - GuruFocus
Stephens cuts Glaukos stock price target to $115 from $140 - Investing.com
Glaukos Corporation (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
1.70%
자본화:
|
볼륨(24시간):